| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 41.6 | 25.3 | 33.9 |
| Other income | 0.6 | 0.3 | 0.1 |
| Total income | 42.3 | 25.6 | 34.0 |
| Profit before exceptional items & tax | 10.2 | -1.0 | 7.5 |
| Profit before tax | 10.2 | -1.0 | 7.5 |
| Net profit | 7.4 | -0.8 | 5.6 |
| Operating margin | 24.1% | -3.9% | 22.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +32.10% |
|---|---|
| Revenue, year on year | +22.70% |
NSE results filing, NSE: AAKAAR. Figures extracted from the filing.
Aakaar Medical Technologies Ltd: key numbers
- Share price
- ₹70.00
- Market cap
- ₹99.21 Cr
- Revenue (annual)
- ₹66.96 Cr
- Net profit (annual)
- ₹6.64 Cr
- P/E (TTM)
- 14.9×Sector 57.8×
- Promoter holding
- 67.05%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aakaar Medical Technologies Ltd
All →Aakaar Medical Technologies Earnings Call: Key Takeaways
Aakaar Medical Technologies reported FY26 revenue of INR 67 Cr (up 8.6%) and PAT of INR 6.63 Cr (up 10%). The company is shifting towards an asset-light DODO clinic model via its Xelix platform.
Aakaar Medical Technologies Earnings Call: Key Takeaways
Aakaar Medical Technologies reported strong FY26 recovery with ₹66.9cr revenue and record H2 profitability driven by high-margin product launches and improved debtor discipline.
Aakaar Medical Technologies Earnings Call: Key Takeaways
Aakaar Medical Technologies reported H2FY26 revenue of ₹41.6 Cr and PAT of ₹7.4 Cr, successfully pivoting to higher-margin owned brands and cash-first billing.